An Anges Québec member invests in SyntBioLab
Montreal, July 18th, 2016 – Today Anges Québec is pleased to announce that one of its members is financially backing the growth of SyntBioLab, an innovative biotechnology company specialized in the use of genetic procedures to optimize industrial production in various sectors, such as the agri-food industry, across many international markets.
According to SyntBioLab CEO Rodrigue Dubar, this new capital injection will allow his company to reach new heights: “With our angel investor’s support, we were able to determine the steps our company needs to take it to the next level. Anges Québec gave us the support and tools we need to break through.” In particular, SyntBioLab will use this new source of funding to upgrade its production capacity and distribution networks.
Anges Québec and SyntBioLab advisory committee member Sébastien A. Guay adds, “I firmly believe in SyntBioLab’s and its employees’ potential. I hope that my support helps this dedicated team achieve its full potential.” For Mr. Guay, the company’s potential stems from its ability to judiciously use in-house state-of-the-art technologies that provide new and effective solutions to important and very common problems affecting industrial production.
SyntBioLab has international expansion ambitions
Based in Lévis, SyntBioLab develops new bacteria strains that improve manufacturing processes, particularly in the dairy industry, protein production, and bacteriological population biocontrol. The company’s recent growth has allowed it to expand its business network into certain Asian and European markets. SyntBioLab hopes to expand globally.
SyntBioLab Inc. is a knowledge-based bioengineering company that offers high-rate metabolic optimization services related to industrial microorganisms. It accelerates and guides the evolution of productivity-increasing microbes involved in certain industrial processes to develop phenotypes that improve the competitiveness of its clients.
Information and interviews